Abstract Primary small cell neuroendocrine carcinoma is uncommon in head and neck region, with occasional cases in nasopharynx. Distinction from other round cell tumors is imperative to ensure optimal patient management. We present a case of a 30-year-old woman who presented with a rapidly growing nasopharyngeal mass.
Introduction
Small cell neuroendocrine carcinoma (SmNEC) is a distinct malignant neoplasm, most frequently arising in the lung. Extrapulmonary SmNECs account for approximately 5% of all SmNECs, and have been reported at various sites such as esophagus, and pancreas [1, 2] . In the head and neck, sporadic cases have been reported in larynx, and salivary glands [3] . SmNEC of nasopharynx is exceedingly rare, with only fourteen cases reported in literature ( Table 1) . Distinction of SmNEC from other small round cell tumors found here is vital, as they have a dismal clinical course and poor response to therapy; however, this is often a challenge due to overlapping pathology features [4] . We present a case of SmNEC presenting as a nasopharyngeal mass, and discuss the differential diagnoses.
Case Report
A 30-year-old female presented with complaints of nasal obstruction for 4 months, and few episodes of epistaxis. On examination, a 6 9 5 cm mass was seen in the nasopharynx. Imaging showed an expansile, heterogeneous mass along the posterior nasopharyngeal wall, extending inferiorly into the oropharynx, anteriorly into the nasal cavity, and infiltrating the hard palate. Cystic spaces denoting necrosis were also seen. A biopsy was taken from the hard palate, following which the patient did not return to OPD. Three months later, she presented with increase in size of the mass, a new swelling on right side of neck which was associated with pain, hoarseness of voice, and difficulty in swallowing. On examination, the primary tumor had increased in size, and enlarged level II, III and IV cervical lymph nodes were identified. A second biopsy was performed from the nasopharyngeal mass. Microscopically, although the first biopsy was small, both biopsies showed similar morphological features (Figs. 1, 2) . The tumor was composed of nests of small round cells, with large areas of necrosis, and marked crushing. Tumor cells had scant cytoplasm, hyperchromatic nuclei with stippled chromatin, and inconspicuous nuclei. Nuclear molding was noted. Many interspersed neutrophils were seen. Foci of perineural infiltration were identified.
On immunohistochemistry (IHC), the first biopsy ( Fig. 1d-f) showed focal granular positivity for pancytokeratin (CK), while it was negative for leukocyte common antigen (LCA), chromogranin and synaptophysin. Further IHC could not be performed as the tumor tissue was exhausted, and a diagnosis of poorly differentiated carcinoma was made. The second biopsy (Fig. 2d-f ) revealed immunopositivity for CD56, CK, and chromogranin (focal); synaptophysin and p40 were negative. Ki-67 labelling index was high (90%). A diagnosis of SmNEC of the nasopharynx was made. However, the patient's condition deteriorated due to rapid progression of disease, and she expired before treatment could be initiated.
Discussion
Neuroendocrine carcinomas (NECs) of the head and neck can be classified into well-differentiated NEC (carcinoid), moderately-differentiated NEC (atypical carcinoid), and poorly-differentiated NECs, the latter being divided further into small cell and large cell neuroendocrine carcinomas [5, 6] . The cell of origin of these tumors remains a subject for debate, with one hypothesis being that they arise from the cells of the dispersed neuroendocrine system, while another group believes that these tumors originate from pluripotent stem cells capable of dual epithelial and endocrine differentiation [7, 8] .
SmNEC is infrequently encountered in extrapulmonary locations. In head and neck region, larynx is the most common site (0.5-1% of carcinomas), followed by salivary glands [3, 9] . Neuroendocrine tumors of the nasopharynx are extremely infrequent, and primary nasopharyngeal SmNEC remains a rare entity [10] . Majority of patients present in 5th-6th decades; occasional cases have been reported in younger patients, including in children [11] . Clinical presentation is non-specific, resembling other malignancies of this region. Common symptoms include nasal obstruction, rhinorrhea and epistaxis, with some AWD alive with disease, CR complete remission, DOD dead of disease, NED no evidence of disease, PD progressive disease, PR partial remission, RT radiotherapy, STR sub-total resection Fig. 1 Biopsy from the hard palate shows an infiltrating small round cell tumor (a HE, 9100) whose cells have scant cytoplasm, and hyperchromatic nuclei with focal nuclear molding (arrows) (b HE, 9400); perineural infiltration was present (c HE, 9200).
Immunohistochemistry shows dot-like cytokeratin positivity (d IHC, 9400) while chromogranin (e IHC, 9200) is negative. Ki-67 labelling index is moderately high (f IHC, 9400) Fig. 2 Second biopsy shows a tumor beneath the nasal mucosal lining (a HE, 9100) which is infiltrating the underlying bone (b HE, 9200) and has histomorphological features similar to the previous biopsy (c HE, 9400). Diffuse cytokeratin (d IHC, 9200), and focal chromogranin (e IHC, 9400) and CD56 positivity (f IHC, 9200) is seen patients presenting with symptoms of local invasion such as hearing loss, tinnitus, exophthalmos, and restricted eye movements [10] . Paraneoplastic syndromes may also be associated, due to the secretion of various hormones [10] . SmNEC may occur as a second malignancy after radiotherapy for nasophayngeal carcinoma [12] . Metastases to neck nodes have been reported in only few cases [11] [12] [13] . Our patient presented with nasal obstruction and epistaxis, and developed cervical lymphadenopathy rapidly in the course of the disease. Histopathological diagnosis remains a challenge due to the overlapping morphological features with other small round cell tumors. Differential diagnosis includes nasopharyngeal carcinoma (NPC), basaloid squamous cell carcinoma (BSCC), ONB, malignant melanoma, rhabdomyosarcoma, malignant lymphoma, Ewing sarcoma, and SmNEC [14] . Immunohistochemistry plays an important part in distinguishing these entities which differ in their management and prognosis. Chapman-Fredricks et al. [15] found that CK alone could narrow down the diagnostic possibilities among nasopharyngeal malignancies by excluding melanoma, rhabdomyosarcoma and lymphoma. For epithelial tumors, this distinction was more difficult. However, a limited panel including CK (positive in all epithelial tumors, with dot-like positivity in SmNEC), CK5/6 (positive in NPC and BSCC; negative in SmNEC), p63 (positive in all epithelial tumors except SmNEC), and HLA-DR (positive in NPC), could discriminate between most cases. While staining with neuroendocrine markers helps identify SmNEC, it is often focal or of weak intensity, and may even be negative, as in the first biopsy from our patient [13, 15, 16] . In the second biopsy also, staining for neuroendocrine markers CD56 and chromogranin was seen only focally, and synaptophysin was completely negative. Another important differential diagnosis is the recently described NUT midline carcinoma (NMC), which frequently occurs in head and neck [17] . NMC shows strong nuclear positivity with p40 and NUT, aiding in its distinction. Lastly, another hurdle to arriving at the diagnosis of SmNEC is the paucity of viable tumor tissue in small biopsies, resulting in multiple biopsies being required before a final diagnosis is made. Unlike NPC, no convincing evidence establishing the pathogenetic role of Epstein Barr virus (EBV) in nasopharyngeal NECs has been found, suggesting that EBV EBER-ISH detection may be valuable in distinguishing SmNEC from NPC [16] .
Owing to the scarcity of reported cases, no definite treatment protocols exist for nasopharyngeal SmNEC at present. Due to their aggressiveness, most patients require a combination of therapeutic modalities [18] . Surgery followed by chemo-radiotherapy achieved a better response than chemo-radiotherapy alone [19] . Initial complete response to chemo-radiation, however, has been reported to be followed by development of distant metastasis [18] .
Like its pulmonary counterpart, nasopharyngeal SmNEC behaves aggressively, and despite early detection and initial response to treatment, has poor prognosis [3, 16] . Mean survival for head and neck SmNEC is 14.5 months with estimated 5-year-survival rate being 13% [20] . Nasopharyngeal SmNEC has the shortest overall survival among all head and neck locations, with median survival of 15.1 months, as compared to 36.4 months for nasal cavity SmNECs [21] . Overall survival is significantly shorter for head and neck SmNEC patients with nodal involvement, averaging at 20.8 versus 43.9 months in those without lymph node disease [21] .
Thus, SmNEC of the nasopharynx is a rare entity with an aggressive clinical course. Careful morphological evaluation and immunohistochemistry play a central role in diagnosing this neoplasm. Proper diagnostic criteria and treatment protocols need to be established to detect cases at an early stage and manage them appropriately, in order to limit morbidity and mortality.
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